{"claimId":"clm_ec_saf_mood","grade":"B","version":0,"status":"current","verdict":"Saffron for mood: Grade B at moderate certainty. multiple RCTs show benefit for mild-to-moderate depressive symptoms, comparable to low-dose SSRIs in small trials","direction":"benefit","magnitude":{"metric":"other","value":null,"unit":"","ci95":null,"humanReadable":"multiple RCTs show benefit for mild-to-moderate depressive symptoms, comparable to low-dose SSRIs in small trials","baselineAbsoluteRisk":null},"certainty":"moderate","clinicalMeaning":"small_but_potentially_useful","applicability":{"appliesTo":["adults with mild-moderate depression"],"doesNotApply":[],"unknown":[]},"safetyQualifiers":[],"evidenceBundleId":"eb_ec_saf_mood","citations":[{"pmid":"34757208","design":"peer-reviewed"}],"reviewedBy":null,"reviewedAt":"2026-07-16T05:20:15.103Z","dateModified":"2026-07-16T05:20:15.103Z","methodologyVersion":"v1","methodologyDoi":"https://doi.org/10.5281/zenodo.21364236","canonicalUrl":"https://evidencebased.info/interventions/saffron/mood","attribution":"Substrate (evidencebased.info), claim clm_ec_saf_mood v0, reviewed 2026-07-16","license":"CC-BY-4.0 proposed; reuse license pending governance ratification","governanceMode":"legacy","governanceStatus":"legacy-unverified","dataSource":"live"}